Ischaemia modified albumin in patients with acute coronary syndrome and negative cardiac troponin I

References

• Lin JC, Apple FS, Murakami MM, Luepker RV. Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes. Clin Chem 2004;50:333–8.
   PubMed Web of Science ®Google Scholar
• Ritter D, Lee PA, Taylor JF, Hsu L, Cohen JD, Chung HD, Virgo KS. Troponin I in patients without chest pain. Clin Chem 2004;50:112–9.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneus transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin and troponin I. Am Heart J 2001; 141:985–91.
   PubMed Web of Science ®Google Scholar
• Christenson RH, Duh SH, Sanhal WR, Wu AHB, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464–70.
   PubMed Web of Science ®Google Scholar
• Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, Rios CN, Sugiyama CE, Ha C-E. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581–5.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Vollinson P, Kaski JC. Ischemia modified albumin for assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004;97: 297–301.
   PubMed Web of Science ®Google Scholar
• Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre AW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutric D, Sinha MK, Uettwiller-Geiger D, Pollack CV. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndrome in the emergency department. Am Heart J 2006;152:253–62.
   PubMed Web of Science ®Google Scholar
• Lippi G, Montagnana M, Guidi GC. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol 2006;108:410–11.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Sinha M, Floros D, Gaze D, Coinson P, Baxter GF, Kaski JC. Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am J Cardiol 2004;94:234–6.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Collinson P, Kaski JC. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 2004;93:366–8.
   PubMed Web of Science ®Google Scholar
• Gugliucci A, Hermo R, Monroy C, Numaguchi M, Kimura S. Ischemia-modified albumin levels in cord blood: a case control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005;362:155–60.
   PubMed Web of Science ®Google Scholar
• Refaai MA, Wright RW, Parvin CA, Gronowski AM, Scott MG, Eby CS. Ischemia-modified albumin increases after skeletal ischemia during arthroscopic knee surgery. Clin Chim Acta 2006;366:264–8.
   PubMed Web of Science ®Google Scholar
• Troxler M, Thompson D, Homer-Vanniasinkam S. Ischaemic skeletal muscle increases serum ischaemia modified albumin. Eur J Vasc Endovasc Surg 2006;31:164–9.
   PubMed Web of Science ®Google Scholar
• Lee Y-W, Kim H-J, Cho Y-H, Shin H-B, Choi T-Y, Lee Y-T. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Clin Chim Acta 2007;384:24–7.
   PubMed Web of Science ®Google Scholar
• Apple FS, Wu AF, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS, Committe on Standarization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810–24.
   PubMed Web of Science ®Google Scholar
• Sinha M, Roy D, Gaze D, Coinson PO, Kaski JC. Role of ischemia modified albumin, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29–34.
   PubMed Web of Science ®Google Scholar
• Marx G, Chevion M. Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate. Biochem J 1985;236:397–400.
   Google Scholar
• Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, Quiles J, Gaze DC, Kaski JC. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 2004;93:88–90.
   PubMed Web of Science ®Google Scholar
• Hjortsoj S, Dethlefsen C, Kristensen SR, Ravkilde J. Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia. Clin Chim Acta 2009;403: 114–20.
   PubMed Web of Science ®Google Scholar
• Hochholzer W, Morrow DA, Giugiano RP. Novel biomarkers in cardiovascular disease: update 2010. Am Heart J 2010;160:583–94.
   PubMed Web of Science ®Google Scholar
• Omland T. New features of troponin testing in different clinical settings. J Intern Med 2010;268:207–17.
   PubMed Web of Science ®Google Scholar
• Shem X-I, Lin C-J, Han L-I, Lin L, Pan L, Pu X-D. Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome. Int J Cardiol 2011;149:296–8.
   PubMed Web of Science ®Google Scholar
• Van Belle E, Dallongeville J, Vicaut E, Degrandsart A, Baulac C, Montalescot G, OPERA Investigators. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. Am Heart J 2010;159:570–6.
   PubMed Web of Science ®Google Scholar